Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma;Značaj patohistološkog nalaza i ekspresije Bcl-2 za prognozu i lečenje oralnog planocelularnog karcinoma

Vojnosanitetski Pregled

Volumn 69, Issue 4, 2012, Pages 314-319

  Lončarević, Slobodan ^a   Vignjević, Sanja ^b   Jović, Nebojša ^a   Aćimović, Ljubiša ^c   Gardašević, Milka ^a   Todorović, Vera ^b   Dimitrijević, Jovan ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Institut za medicinska istra ivanja   (Serbia)

^c Klinika za hirurgiju   (Serbia)

Author keywords

Biological; Carcinoma; Histological tehniques; Immunohistochemistry; Mouth neoplasms; Prognosis; Squamous cell; Treatment outcome; Tumor markers

Indexed keywords

PROTEIN BCL 2;

ADIPOSE TISSUE; ANALYTICAL PARAMETERS; ARTICLE; BONE TISSUE; CANCER GRADING; CANCER INFILTRATION; CANCER MORPHOLOGY; CANCER STAGING; CANCER TISSUE; CONNECTIVE TISSUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MUSCLE TISSUE; NUCLEAR RATIO; NUCLEOCYTOPLASMIC RATIO; ORAL SURGERY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84859175124     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1204314L     Document Type: Article

References (25)

1. Kozomara R, Jović N, Vukelić-Marković S, Broćić M, Dimitrijević J, Nikolajević S. Importance of histopathological analysis for diagnosis, treatment and follow-up of patients with squamocellular carcinoma of the tongue and mouth floor. Arch Oncol 2002; 10(Suppl 1): 139-40.
2. Dimitrijević M, Ješić S, Konstantinović V. Incidence and mortality of oral cavity carcinomas in central Serbia. J BUON 2001; 6: 183-7.
3. Dimitrijević J. Clinical pathology. Srp Arh Celok Lek 2006; 134(Suppl 1): 78-83. (Serbian)
4. Wilson GD, Saunders MI, Dische S, Richman PI, Daley FM, Bentzen SM. Bcl-2 expression in head and neck cancer: an enigmatic prognostic marker. Int J Radiat Oncol Biol Phys 2001; 49(2): 435-41.
5. Rodrigo JP, Coto E, González MV, Maldonado M, Suárez C. P53 allelic loss and outcome in patients with squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2001; 258(5): 255-8.
6. Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Forteza J, Fraga M. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology. J Oral Pathol Med 2010; 39(7): 571-8.
7. Scully C, Sudbø J, Speight PM. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med 2003; 32(5): 251-6.
8. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998; 16: 395-419.
9. Lo Muzio L, Santarelli A, Panzarella V, Campisi G, Carella M, Ciavarella D, et al. Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis. Minerva Stomatol 2007; 56(6): 341-7. (English, Italian)
10. Smilek P, Dusek L, Veselý K, Rottenberg J, Kostrica R. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer. Neoplasma 2005; 52(3): 199-207.
11. Papavasileiou D, Tosios K, Christopoulos P, Goutas N, Vlachodimitropoulos D. Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification. Head Neck Pathol 2009; 3(4): 263-70.
12. Lopes MA, Nikitakis NG, Reynolds MA, Ord RA, Sauk J Jr. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma. J Oral Maxillofac Surg 2002; 60(2): 142-7; discussion 147-8.
13. Lothaire P, de Azambuja E, Dequanter D, Lalami Y, Sotiriou C, Andry G, et al. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006; 28(3): 256-69.
14. {Eth}ukić V, Janošević LB, Dimitrijević M, Damjanović SS., Peško P, Dotlić J. Genetic markers for head and neck cancers-current state of art and perspectives. Jugosl Med Biohem 2003; 22(4): 273-82. (Serbian).
15. Yuen AP, Lam KY, Choy JT, Ho WK, Wong LY, Wei WI. Clinicopathologic significance of bcl-2 expression in the surgical treatment of oral tongue carcinoma. Eur J Surg Oncol 2002; 28(6): 667-72.
16. van Oijen MG, Leppers Vd Straat FG, Tilanus MG, Slootweg PJ. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 2000; 88(4): 884-93.
17. Friedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM, et al. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001; 23(4): 280-5.
18. Gallo O, Boddi V, Calzolari A, Simonetti L, Trovati M, Bianchi S. bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy. Clin Cancer Res 1996; 2(2): 261-7.
19. Broćić M, Kozomara R, Cerović S, Jović N, Vukelić-Marković S, Stosić S. Clinical significance of vascular endothelial growth factor expression in patients with carcinoma of the mouth floor and tongue. Vojnosanit Pregl 2009; 66(6): 440-8.
20. Motta Rda R, Zettler CG, Cambruzzi E, Jotz GP, Berni RB. Ki-67 and p53 correlation prognostic value in squamous cell carcinomas of the oral cavity and tongue. Braz J Otorhinolaryngol 2009; 75(4): 544-9.
21. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162(4): 285-94.
22. Can B, Sökmensüer C. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Hepatogastroenterology 2003; 50 Suppl 2: ccxliii-ccxlviii.
23. Bayazit Y, Bakir K, Ucak R, Mumbuc S, Ozer E, Kanlikama M. Clinical and histopathological correlates of the proliferative activity in squamous cell laryngeal carcinoma. Rev Laryngol Otol Rhinol (Bord) 2002; 123(1): 43-6.
24. Jordan RC, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol 1996; 32B(6): 394-400.
25. Xie X, Clausen OP, De Angelis P, Boysen M. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999; 86(6): 913-20.